BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20843323)

  • 1. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
    Welcker JT; Nawroth F; Bilger W
    Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
    Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
    Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
    Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
    Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
    Porter R; Kissel C; Saunders H; Keck C
    Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
    Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
    Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.
    Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G
    Patient Prefer Adherence; 2014; 8():813-26. PubMed ID: 24940048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing infertility with the follitropin alfa prefilled pen injector - patient considerations.
    Bühler K
    Ther Clin Risk Manag; 2015; 11():995-1001. PubMed ID: 26170678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
    Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
    BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt.
    Yehia M; El-Khayat W; Kortam A; Mowafy AH; Aziz Khalifa AA; Awad A; Khattab S
    Curr Med Res Opin; 2013 Nov; 29(11):1429-34. PubMed ID: 23899053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.
    Agostinetto R
    Reprod Biol Endocrinol; 2009 May; 7():48. PubMed ID: 19450267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A redesigned follitropin alfa pen injector for infertility: results of a market research study.
    Abbotts C; Salgado-Braga C; Audibert-Gros C
    Patient Prefer Adherence; 2011; 5():315-31. PubMed ID: 21792303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study.
    Sydow P; Gmeinwieser N; Pribbernow K; Keck C; Wiegratz I
    Reprod Biol Endocrinol; 2020 May; 18(1):54. PubMed ID: 32456636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotrophin products: empowering patients to choose the product that meets their needs.
    Weiss N
    Reprod Biomed Online; 2007 Jul; 15(1):31-7. PubMed ID: 17623531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
    Bühler KF; Fischer R; Verpillat P; Allignol A; Guedes S; Boutmy E; Bilger W; Richter E; D'Hooghe T
    Reprod Biol Endocrinol; 2021 Jun; 19(1):90. PubMed ID: 34134695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The redesigned follitropin α pen injector for infertility treatment.
    Christen M; Schertz JC; Arriagada P; Keitel J; Müller H
    Expert Opin Drug Deliv; 2011 Jun; 8(6):833-9. PubMed ID: 21548843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
    Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
    Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.
    Bühler K; Naether OG; Bilger W
    Reprod Biol Endocrinol; 2014 Jan; 12():6. PubMed ID: 24423045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of the administration of follitropin-beta with a pen device.
    Bruynesteyn K; Bonsel GJ; Braat DD; Fauser BC; Devroey P; van Genugten ML
    Reprod Biomed Online; 2005 Jul; 11(1):26-35. PubMed ID: 16102283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.